Reproductive Medicine, Department of Obstetrics and Gynecology, Tzafon Medical Center, Poriya, Israel.
Azrieili Faculty of Medicine in Galilee, Bar-Ilan University, Safed, Israel.
Front Endocrinol (Lausanne). 2024 May 10;15:1397279. doi: 10.3389/fendo.2024.1397279. eCollection 2024.
Currently, three crucial questions regarding the reliability of ovarian reserve measures in women with ovarian endometrioma during the reproductive age are being discussed. Firstly, the effects of endometriotic cystectomy on short and long-term ovarian reserve. Secondly, the accuracy of serum anti-Müllerian hormone (AMH) and antral follicle count (AFC) in estimating ovarian reserve in these cases. Thirdly, the impact of endometrioma itself on the ovarian reserve over time in such cases. The purpose of the present review is to critically assess available systematic reviews and meta-analyses that have explored these questions. Nine eligible reviews were found following a systematic search on PubMed.com and similarly assessed. These reviews varied considerably regarding the level of evidence, as per an identical comprehensive scoring system. Moderate to high-quality evidence demonstrates that endometriotic cystectomy, by the stripping technique, adversely affects ovarian reserve in the short and long term, up to 9-18 months post-surgery. Damage to ovarian reserve was considerable but more pronounced in bilateral cases than unilateral cases, equivalent to 39.5% and 57.0%, respectively. Repeat endometriotic cystectomy is detrimental to ovarian reserve. The impact of endometrioma diameter on ovarian reserve before or after surgery is still unclear. Moderate to high-quality evidence, relying on simultaneous assessment of both ovarian reserve measures, shows that AMH is sensitive while AFC is not in cases undergoing ovarian cystectomy. AMH should be the biomarker of choice for counseling and managing women with endometrioma in their reproductive age, especially before surgery. While there is some evidence to show that endometrioma per se may harm ovarian reserve, this evidence is not robust, and there is good-quality evidence to challenge this notion. It is necessary to conduct further targeted RCTs, systematic reviews, and meta-analyses based on solid methodological grounds to increase the level of evidence, refine quantitative estimates, investigate open questions, and decrease heterogeneity.
目前,针对生育期卵巢子宫内膜异位症患者卵巢储备功能评估指标的可靠性,存在三个关键问题:其一,卵巢子宫内膜异位囊肿剔除术对短期和长期卵巢储备的影响;其二,血清抗苗勒管激素(AMH)和窦卵泡计数(AFC)评估此类患者卵巢储备的准确性;其三,卵巢内异症囊肿本身对卵巢储备的长期影响。本综述旨在批判性评估针对这些问题的系统评价和荟萃分析。通过在 PubMed.com 上进行系统检索,共找到 9 篇符合条件的综述,并进行了类似的评估。这些综述在证据水平方面存在较大差异,采用了相同的全面评分系统。中高质量证据表明,经囊肿剔除术(包括剥除术)后,卵巢储备在短期和长期(术后 9-18 个月)均受到不利影响,其中以剥离术为甚。单侧与双侧手术相比,卵巢储备的损害程度更为显著,分别为 39.5%和 57.0%。重复手术对卵巢储备也有不良影响。手术前后囊肿直径与卵巢储备的关系仍不清楚。中高质量证据(同时评估两种卵巢储备指标)表明,在接受卵巢囊肿切除术的患者中,AMH 比 AFC 更为敏感。在生育期接受手术的内异症患者中,AMH 应作为首选的生物标志物,用于咨询和管理。虽然有一些证据表明内异症囊肿本身可能会损害卵巢储备,但这些证据并不充分,高质量证据也对这一观点提出了挑战。有必要在坚实的方法学基础上,进一步开展有针对性的 RCT、系统评价和荟萃分析,以提高证据水平、细化定量估计、探索悬而未决的问题并降低异质性。